Le Lézard
Classified in: Health, Science and technology

/C O R R E C T I O N -- Savii Inc./


In the news release, Savii Partners with Maxwell Healthcare Associates as Private Duty Solution Consultant, issued 21-Jan-2020 by Savii Inc. over PR Newswire, we are advised by the company that the second paragraph, first sentence, should read "Additionally, Maxwell will be a resource to support implementation and training as Savii brings larger customers on board." rather than "Additionally, Maxwell will be a resource to support implementation and training as Savii increases their larger customer base." We also have been advised that the third paragraph should read "We are honored to be among the first private duty EHR platforms to formally align with Maxwell. Adding their talent to our portfolio of services means we have more expert resources available to accelerate new customers' go-live cycles and more quickly realize an ROI with Savii," said Savii CEO Kristen Duell. "Current agency clients will have access to unmatched consulting services, with in-depth Savii knowledge, to optimize their operations and expand their businesses." rather than "Kristen Duell, Savii CEO, explains, "We are honored to be among the first EHR platforms to formally align with Maxwell. Adding their talent to our portfolio of services increases our expert resources available to accelerate new customers' go-live cycles and more quickly realize an ROI with Savii. Current agency clients will have access to unmatched consulting services, with Savii knowledge, to optimize their operations or even expand their business." Lastly, we are advised that the fourth paragrah, third sentence should read "This formula allows us to provide next-level service and expertise to our multi-service-line clients and their patients," said Maxwell co-founder and co-CEO Jennifer Maxwell." rather than "This formula allows us to provide next-level service and expertise in to our multi-service line clients and their patients," said co-founder and co-CEO Jennifer Maxwell." as originally issued inadvertently. The complete, corrected release follows:

Savii Partners with Maxwell Healthcare Associates as Private Duty Solution Consultant

TAMPA, Fla., Jan. 21, 2020 /PRNewswire/ -- Tampa-based Savii, Inc., is delighted to announce a formal partnership with industry leading healthcare consulting firm, Maxwell Healthcare Associates.  Maxwell will provide strategic development insights as Savii continues to release value-added functionality within its agency management software. 

Savii_Logo

Additionally, Maxwell will be a resource to support implementation and training as Savii brings larger customers on board. Current Savii customers will have access to additional resources to advance their business through various consulting engagements that address operational inefficiencies they struggle with in their workflow.

"We are honored to be among the first private duty EHR platforms to formally align with Maxwell. Adding their talent to our portfolio of services means we have more expert resources available to accelerate new customers' go-live cycles and more quickly realize an ROI with Savii," said Savii CEO Kristen Duell. "Current agency clients will have access to unmatched consulting services, with in-depth Savii knowledge, to optimize their operations and expand their businesses."

"We pride ourselves on being the leader in post-acute healthcare consulting. We want to partner with those who can best serve our clients from all angles. This formula allows us to provide next-level service and expertise in to our multi-service line clients and their patients," said Maxwell co-founder and co-CEO Jennifer Maxwell.

Together, this pairing of top-tier companies brings access to world-class consulting and private duty software solutions.

About Savii
Savii is a Home Care technology provider that believes in designing and developing agency management and point-of-care solutions that transform the way care is delivered in the home. Innovation is at the heart of everything Savii does. Savii is owned by United Kingdom-based H.A.S. Technology Group.  www.saviicare.com 

About Maxwell Healthcare Associates  
Tom and Jennifer Maxwell founded MHA to help their friends in the post-acute healthcare space succeed amid healthcare's transition from volume to value. Providers have tighter budgets with less room for error and need to be more efficient than ever. That's where outside and knowledgeable perspectives become invaluable and necessary. Tom and Jennifer have assembled the most elite group of experts with a combined knowledge base unlike any other consulting team in the industry to help home health, hospice and private duty providers best optimize their operational, technological, regulatory, clinical and financial processes. Their core services include EMR implementations, optimizations and M&A work. For more information visit: https://www.maxwellHCA.com

SOURCE Savii Inc.


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: